Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Legal
News

PG&E Wins Support From Key Bondholders for Restructuring Plan

byCharles Gross

January 22, 2020

1 minute read

-Bloomberg

https://www.bloomberg.com/news/articles/2020-01-22/pg-e-wins-support-from-elliott-pimco-for-restructuring-plan?srnd=markets-vp&sref=V7uxlNge

$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today

By Benzinga Insights

Today, 8:58 PM

Thermo Fisher Scientific (NYSE:TMO) has outperformed the market over the past 15 years by 9.62% on an annualized…

TMO

Truist Securities Maintains Buy on Zscaler, Raises Price Target to $400

By Benzinga Newsdesk

Today, 8:58 PM

Truist Securities analyst Joel Fishbein maintains Zscaler (NASDAQ:ZS) with a Buy and raises the price target from $325 to $400.

Here’s How Much $100 Invested In Applied Materials 10 Years Ago Would Be Worth Today

By Benzinga Insights

Today, 8:58 PM

Applied Materials (NASDAQ:AMAT) has outperformed the market over the past 10 years by 13.06% on an annualized basis producing an average annual return of 23.99%. Currently, Applied Materials has a market capitalization of $77.61 billion.

AMAT

HC Wainwright & Co. Initiates Coverage On Kintara Therapeutics with Buy Rating, Announces Price Target of $6

By vishwanath@benzinga.com

Today, 8:58 PM

HC Wainwright & Co. analyst Michael King initiates coverage on Kintara Therapeutics (NASDAQ:KTRA) with a Buy rating and announces Price Target of $6.

KTRA

PG&E Wins Support From Key Bondholders for Restructuring Plan

Related Posts

$1000 Invested In Thermo Fisher Scientific 15 Years Ago Would Be Worth This Much Today

Truist Securities Maintains Buy on Zscaler, Raises Price Target to $400

Here’s How Much $100 Invested In Applied Materials 10 Years Ago Would Be Worth Today

HC Wainwright & Co. Initiates Coverage On Kintara Therapeutics with Buy Rating, Announces Price Target of $6